Lataa...
Cardiac ryanodine receptor in metabolic syndrome: is JTV519 (K201) future therapy?
Metabolic syndrome is characterized by a combination of obesity, hypertension, insulin resistance, dyslipidemia, and impaired glucose tolerance. This multifaceted syndrome is often accompanied by a hyperdynamic circulatory state characterized by increased blood pressure, total blood volume, cardiac...
Tallennettuna:
| Päätekijä: | |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2012
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3340112/ https://ncbi.nlm.nih.gov/pubmed/22563249 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DMSO.S30005 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|